Skip to content

Abstract 11455: Deletion of ASGR1 Suppresses Atherosclerosis

Nov 2026 · Circulation · 0 citations

Abstract

Introduction: A loss-of-function mutation in the asialoglycoprotein receptor 1 (ASGR1) associates with reduced coronary artery disease (CAD) risk, suggesting a role in atherosclerosis. We aimed to determine if ASGR1 deletion causes atheroprotection in stable and unstable atherosclerosis, and elucidate changes in macrophage function and immune cells. Methods: Western blotting, immunofluorescence and flow cytometry assessed ASGR1 expression in bone marrow-derived macrophages (BMDMs), immune cells and plaque. Apolipoprotein ( Apo ) e -/- , Apoe -/- Asgr1 +/- and Apoe -/- Asgr1 -/- mice were fed high-cholesterol diet (HCD) to develop early-stage (8-weeks HCD) and established (16-weeks HCD) stable plaque. The tandem stenosis model assessed plaque instability. Immune cells changes were determined by flow cytometry in blood, aorta, liver and lymph nodes. Plasma and liver lipids were assessed enzymatically. Wildtype, Asgr1 +/- and Asgr1 -/- BMDMs were subjected to cholesterol efflux and oxidised low-density lipoprotein (oxLDL) uptake assays. Results: ASGR1 protein is expressed in cultured BMDMs and murine plaque, and in a host of immune cells in blood, aorta, liver and lymph nodes (LNs). Atherosclerotic Apoe -/- Asgr1 -/- mice developed smaller early-stage (-37%) and established (-22%) stable plaques in aortic sinuses than Apoe -/- mice, P <0.05. Apoe -/- Asgr1 -/- developed smaller unstable plaques (-36%) with less lipid (-65%) and fewer macrophages (-77%), and increased stability including fewer erythrocytes (-82%) and increased smooth muscle cells (+62%), P <0.05. For each model, plasma and liver lipids were unchanged between groups. Apoe -/- Asgr1 -/- mice had fewer aortic monocytes (-38%), inflammatory M1-like (-40%), fatty TREM2+ (-77%) and anti-efferocytotic CD47+ (-54%) macrophages than Apoe -/- mice, P <0.01. Apoe -/- Asgr1 -/- livers and iliac LNs also had fewer M1-like (Livers: -60%; LNs: -31%) and TREM2+ (Livers: -77%; LNs: -36%) macrophages, P <0.01. Circulating and aortic cytotoxic CD8 + T-cells (aorta: -45%; blood: -70%) and NKT cells (aorta: -69%; blood: -49%) were lower in Apoe -/- Asgr1 -/- mice. In vitro , Asgr1 -/- BMDMs elicited more cholesterol efflux (+39%) and less oxLDL uptake (-15%) than wildtype BMDMs, P <0.05. Conclusions: ASGR1 is expressed in macrophages and other immune cells. ASGR1 deletion reduces plaque size and instability, mediated by lowered monocyte, macrophage, CD8 + and NKT cells in aortas, livers, LNs and blood and enhanced macrophage lipid handling functions.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.